Limonoid Triterpene, Obacunone Increases Runt-Related Transcription Factor 2 to Promote Osteoblast Differentiation and Function
Open Access
- 2 March 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (5) , 2483
Abstract
Root bark of Dictamnus dasycarpus Turcz. has been widely used as a traditional medicine and is a well-known anti-inflammatory agent. We isolated limonoid triterpene, obacunone (Obac) from the dried root bark of D. dasycarpus. Obac has been reported to exhibit varieties of biological activities including anti-inflammatory, anti-cancer, and anti-oxidant effects. This study aimed to investigate the beneficial effects and biological mechanisms of Obac in osteoblast differentiation and bone matrix mineralization. In the present study, Obac at concentrations ranging from 1 to 100 μM showed no proliferation effects in MC3T3-E1. The treatment of Obac (1 and 10 μM) increased wound healing and migration rates in a dose-dependent manner. Alkaline phosphatase (ALP) staining and activity showed that Obac (1 and 10 μM) enhanced early osteoblast differentiation in a dose-dependent manner. Obac also increased late osteoblast differentiation in a dose-dependent manner, as indicated by the mineralized nodule formation of ARS staining. The effects of Obac on osteoblast differentiation was validated by the levels of mRNAs encoding the bone differentiation markers, including Alp, bone sialoprotein (Bsp), osteopontin (Opn), and osteocalcin (Ocn). Obac increased the expression of bone morphogenetic protein (BMP), and the phosphorylation of smad1/5/8, and the expression of runt-related transcription factor 2 (RUNX2); Obac also inhibited GSK3β and upregulated the protein level of β-catenin in a dose-dependent manner during osteoblast differentiation. Obac-mediated osteoblast differentiation was attenuated by a BMP2 inhibitor, Noggin and a Wnt/β-catenin inhibitor, Dickkopf-1 (Dkk1) with the abolishment of RUNX2 expression and nuclear accumulation by Obac. Taken together, the findings of this study demonstrate that Obac has pharmacological and biological activates to promote osteoblast differentiation and bone mineralization through BMP2, β-catenin, and RUNX2 pathways, and suggest that Obac might be a therapeutic effect for the treatment and prevention of bone diseases such as osteoporosis and periodontitis.Keywords
Funding Information
- National Research Foundation of Korea (2018R1D1A1B07043282)
This publication has 53 references indexed in Scilit:
- Anti-inflammatory activities of Dictamnus dasycarpus Turcz., root bark on allergic contact dermatitis induced by dinitrofluorobenzene in miceJournal of Ethnopharmacology, 2013
- Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblastsWorld Journal of Stem Cells, 2013
- Changes in cell migration of mesenchymal cells during osteogenic differentiationFEBS Letters, 2011
- Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiationJournal of Cellular Biochemistry, 2011
- The skeleton: a multi-functional complex organ. New insights into osteoblasts and their role in bone formation: the central role of PI3KinaseJournal of Endocrinology, 2011
- Emerging therapeutic opportunities for skeletal restorationNature Reviews Drug Discovery, 2011
- The amazing osteocyteJournal of Bone and Mineral Research, 2010
- Regenerative Effects of Transplanted Mesenchymal Stem Cells in Fracture HealingStem Cells, 2009
- Regulation of bone mass by Wnt signalingJournal of Clinical Investigation, 2006
- Potentiating Effect of Obacunone fromDictamnus dasycarpuson Cytotoxicity of Microtuble Inhibitors, Vincristine, Vinblastine and TaxolPlanta Medica, 2000